EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Differences in chronic lung allograft dysfunction between deceased-donor lung transplantation and living-donor lobar lung transplantation

Satona Tanaka, Mamoru Takahashi, Hidenao Kayawake, Yojiro Yutaka, Akihiro Ohsumi, Daisuke Nakajima, Kohei Ikezoe, Kiminobu Tanizawa, Tomohiro Handa, Hiroshi Date

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2024.10.004 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Satona Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan. Electronic address: satonat@kuhp.kyoto-u.ac.jp. Hauptthemen laut MEDLINE: Lung Transplantation, Living Donors, Primary Graft Dysfunction. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To explore the characteristics and prognostic impact of chronic lung allograft dysfunction (CLAD) after deceased-donor lung transplantation and living-donor lobar lung transplantation, wherein the lower lobes from 2 donors are usually transplanted into one recipient. METHODS: The clinical data of 123 deceased-donor and 67 living-donor lung transplantations performed in adult patients at our institution between June 2008 and September 2019 were retrospectively reviewed. The cumulative incidence of CLAD was evaluated on a per-recipient and per-donor graft basis using the Kaplan-Meier method. RESULTS: A smaller number of human leukocyte antigen mismatches, shorter ischemic time, and lower incidence of grade 3 primary graft dysfunction were observed in living-donor transplantation than in deceased-donor transplantation (P < .001). Restrictive allograft syndrome-type CLAD occurred in 9 (20.9%) of 43 patients with CLAD after deceased-donor transplantation and 9 (45.0%) of 20 patients with CLAD after living-donor transplantation. CLAD occurred unilaterally in 15 patients (75.0%) after bilateral living-donor transplantation. Despite the greater incidence of restrictive allograft syndrome-type CLAD after living-donor transplantation, the overall survival rates after the transplantation and survival rates after the onset of CLAD were comparable between the patients receiving deceased-donor transplants and living-donor transplants. The cumulative incidence of CLAD per recipient was similar between recipients of deceased-donor and the living-donor transplants (P = .32). In the per-donor graft analysis, the cumulative incidence of CLAD was significantly lower in the living-donor grafts than in the deceased-donor grafts (P = .003). CONCLUSIONS: The manifestation of CLAD after living-donor lobar lung transplantation is unique and differs from that after deceased-donor lung transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationLiving DonorsPrimary Graft DysfunctionHumansMaleFemaleRetrospective StudiesMiddle AgedAdultRisk FactorsChronic DiseaseAllograftsIncidenceTreatment OutcomeTime FactorsGraft SurvivalYoung Adult

Stichwörter der Autor:innen

bronchiolitis obliterans syndromechronic lung allograft dysfunctiondeceased-donor lung transplantationhuman leukocyte antigenliving-donor lobar lung transplantationrestrictive allograft syndrome

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan. Electronic address: satonat@kuhp.kyoto-u.ac.jp.
  • Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tanaka, S., Takahashi, M., Kayawake, H., Yutaka, Y., Ohsumi, A., Nakajima, D., Ikezoe, K., Tanizawa, K., Handa, T., & Date, H. (2025). Differences in chronic lung allograft dysfunction between deceased-donor lung transplantation and living-donor lobar lung transplantation. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.10.004

Vancouver

Tanaka S, Takahashi M, Kayawake H, Yutaka Y, Ohsumi A, Nakajima D, et al. Differences in chronic lung allograft dysfunction between deceased-donor lung transplantation and living-donor lobar lung transplantation. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.10.004

BibTeX
@article{Tanaka2025,
  author = {Tanaka, Satona and Takahashi, Mamoru and Kayawake, Hidenao and Yutaka, Yojiro and Ohsumi, Akihiro and Nakajima, Daisuke and Ikezoe, Kohei and Tanizawa, Kiminobu and Handa, Tomohiro and Date, Hiroshi},
  title = {Differences in chronic lung allograft dysfunction between deceased-donor lung transplantation and living-donor lobar lung transplantation},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2024.10.004}
}
Kostenlos starten →